TLR3 and cervical squamous cell carcinoma: Here, the findings indicated that patients with CESC had a longer survival period in both overexpression (roughly 200 months) and underexpression of the TLR3 gene, whereas in UCEC, it was observed that patient survival periods were higher when overexpression (roughly 140) of the TL3 gene was present and lower when underexpression of the TLR3 gene was present.